跳至主要内容
临床试验/JPRN-UMIN000017652
JPRN-UMIN000017652已完成未知

A phase II study of preoperative chemotherapy cosisting docetaxel, oxaliplatin and S-1 for the clinical Stage III gastric cancer - A phase II study of preoperative DOS for cStage III gastric cancer

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine0 个研究点目标入组 50 人开始时间: 2015年5月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Synchronous or metachronous (within 5 years) malignancies except for carcinoma in situ or mucosal tumors curatively treated with local therapy. 2) Past history of severe hypersensitivity to drugs. 3) Active infection. 4) Severe complications (interstitial pneumonia, pulmonary fibrosis, renal failure, liver failure, heart failure, uncontrollable diabetes millutus and Uncontrollable hypertension) 5) Peripheral motor neuropathy or peripheral sensory neuropathy by any reason. 6) Edema of limbs and trunk by any reason. 7) Continuous systemic steroid therapy. 8) Under treatment with flucytosine, phenytoin, or warfarin. 9) Abnormal electrocardiogram or severe cardiovascular disease. 10) Severe diarrhea. 11) Positive HBs antigen. 12) Pregnant women, or women with the possibility of the pregnancy and men who want let to pregnancy.

研究者

发起方
Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine

相似试验